PriceTargets.com logo

NASDAQ:ZY - Zymergen Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $46.00
  • Forecasted Upside: 5.50 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$43.60 As of 06/23/2021 01:00 AM ET
▼ -0.55 (-1.25%)

This chart shows the closing price for ZY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Zymergen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZY

Analyst Price Target is $46.00
▲ +5.50% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $46.00, with a high forecast of $55.00 and a low forecast of $40.00. The average price target represents a 5.50% upside from the last price of $43.60.

This chart shows the closing price for ZY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Zymergen.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/17/2021CowenInitiated CoverageOutperformHigh
5/17/2021Bank of AmericaInitiated CoverageBuy$43.00High
5/17/2021JPMorgan Chase & Co.Initiated CoverageOverweight$40.00High
5/17/2021The Goldman Sachs GroupInitiated CoverageBuy$55.00High
(Data available from 6/23/2016 forward)
Zymergen logo
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Read More

Today's Range

Now: $43.60
Low: $43.38
High: $45.15

50 Day Range

MA: N/A

52 Week Range

Now: $43.60
Low: $25.75
High: $52.00

Volume

198,098 shs

Average Volume

443,579 shs

Market Capitalization

$4.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Zymergen?

The following Wall Street sell-side analysts have issued reports on Zymergen in the last year: Bank of America Co., Cowen Inc, JPMorgan Chase & Co., and The Goldman Sachs Group, Inc..
View the latest analyst ratings for ZY.

What is the current price target for Zymergen?

3 Wall Street analysts have set twelve-month price targets for Zymergen in the last year. Their average twelve-month price target is $46.00, suggesting a possible upside of 5.5%. The Goldman Sachs Group, Inc. has the highest price target set, predicting ZY will reach $55.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $40.00 for Zymergen in the next year.
View the latest price targets for ZY.

What is the current consensus analyst rating for Zymergen?

Zymergen currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ZY will outperform the market and that investors should add to their positions of Zymergen.
View the latest ratings for ZY.

What other companies compete with Zymergen?

Other companies that are similar to Zymergen include Wacker Chemie, Methanex, Fuchs Petrolub, SGL Carbon, NanoXplore, BioLargo, Hardide, good natured Products, Advance NanoTek, Altech Chemicals, Enviroleach Technologies, Fuchs Petrolub, Ganfeng Lithium, good natured Products and HaloSource.

How do I contact Zymergen's investor relations team?

The company's listed phone number is 415 801 8073. The official website for Zymergen is www.zymergen.com.